These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11296622)

  • 1. Role of angiogenesis in the progression and treatment of prostate cancer.
    Choy M; Rafii S
    Cancer Invest; 2001; 19(2):181-91. PubMed ID: 11296622
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenesis and angiogenic mediators in haematological malignancies.
    Mangi MH; Newland AC
    Br J Haematol; 2000 Oct; 111(1):43-51. PubMed ID: 11091181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of angiogenesis in the brain].
    Mennel HD
    Strahlenther Onkol; 2000 Jan; 176(1):46-7. PubMed ID: 10650838
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
    Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
    Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological basis for anti-angiogenic therapy, 8-10 November 1999, Milan, Italy.
    Meade-Tollin LC
    Acta Histochem; 2000 May; 102(2):117-27. PubMed ID: 10824605
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.
    Stewart RJ; Panigrahy D; Flynn E; Folkman J
    J Urol; 2001 Feb; 165(2):688-93. PubMed ID: 11176459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
    Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.
    Figg WD; Dahut W; Duray P; Hamilton M; Tompkins A; Steinberg SM; Jones E; Premkumar A; Linehan WM; Floeter MK; Chen CC; Dixon S; Kohler DR; Krüger EA; Gubish E; Pluda JM; Reed E
    Clin Cancer Res; 2001 Jul; 7(7):1888-93. PubMed ID: 11448901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.
    Giles FJ
    Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of angiogenesis for adjuvant therapy in breast cancer.
    Toi M; Bando H; Kuroi K
    Breast Cancer; 2000; 7(4):311-4. PubMed ID: 11114856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
    Neufeld G; Kessler O; Vadasz Z; Gluzman-Poltorak Z
    Surg Oncol Clin N Am; 2001 Apr; 10(2):339-56, ix. PubMed ID: 11382591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiogenic growth factors in breast cancer progression.
    Kern FG; Lippman ME
    Cancer Metastasis Rev; 1996 Jun; 15(2):213-9. PubMed ID: 8842493
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype.
    Soker S; Kaefer M; Johnson M; Klagsbrun M; Atala A; Freeman MR
    Am J Pathol; 2001 Aug; 159(2):651-9. PubMed ID: 11485923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in the progression of lung cancer.
    Yano S; Goto H; Yamamoto A; Kanematsu T; Sone S
    Intern Med; 2003 Mar; 42(3):305-9. PubMed ID: 12705807
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of tumor growth via inhibition of tumor angiogenesis.
    Plate KH
    Adv Exp Med Biol; 1998; 451():57-61. PubMed ID: 10026850
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis in multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Heider U
    Leuk Res; 2002 Jul; 26(7):701-2. PubMed ID: 12008091
    [No Abstract]   [Full Text] [Related]  

  • 20. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.
    Brat DJ; Van Meir EG
    Am J Pathol; 2001 Mar; 158(3):789-96. PubMed ID: 11238026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.